Optimum management of non-muscle-invasive micropapillary variant urothelial carcinoma: possibility for missed chance of cure?

BJU Int. 2016 Sep;118(3):349-50. doi: 10.1111/bju.13450. Epub 2016 Mar 15.
No abstract available

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Administration, Intravesical
  • BCG Vaccine
  • Carcinoma, Papillary / immunology
  • Carcinoma, Papillary / mortality
  • Carcinoma, Papillary / therapy*
  • Combined Modality Therapy
  • Cystectomy*
  • Humans
  • Immunotherapy*
  • Neoplasm Recurrence, Local
  • Practice Guidelines as Topic
  • Survival Rate
  • Urinary Bladder Neoplasms / immunology
  • Urinary Bladder Neoplasms / mortality
  • Urinary Bladder Neoplasms / therapy*

Substances

  • Adjuvants, Immunologic
  • BCG Vaccine